No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investment
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Clinical trials
It’s time to sit up and take notice of mitochondria
Clinical trials
Biotech Longeveron files for $30M IPO
Clinical trials
Drusolv targets macular degeneration with statin therapy
Drusolv seeks $2 million to prepare IND application for repurposed statin for treatment of AMD ahead of Phase 2 trials.
Clinical trials
New Buck Institute study is treasure trove for longevity research
Clinical trials
Proving the longevity potential of spermidine
Clinical trials
Senolytic start-up gears up for clinical trials
Clinical trials
Gerostate Alpha: “Our phenotype is lifespan”
Clinical trials
“The major modulators of aging remain to be discovered”
Clinical trials
New Longevity supplement targets cognitive decline
Clinical trials
A year in Longevity: progress perspectives
Clinical trials
A year in Longevity: different perspectives
Clinical trials
A year in Longevity: founders’ perspectives
Clinical trials
A year in Longevity: science perspectives
Clinical trials
Longevity biomarker firm to align CROs, pharma and consumers
Clinical trials
BioAge CEO: “It’s all about the data.”
Clinical trials
BioAge lands $90 million; gears up for clinical trials in 2021
Clinical trials
Defining Alzheimer’s by biomarkers could improve clinical trials
Clinical trials
Targeting inflammaging: the hidden “inflammapath” inside us
Clinical trials
Let’s initiate trials of potential geroprotective therapies
Clinical trials
AgelessRx and funding an IRB-approved rapamycin trial
Clinical trials
COVID-19: Leading clinician calls for focus on the biology of aging
Clinical trials
Big Brother approach to accelerate preclinical studies
Clinical trials
ChromaDex releases results for NR study in C19 patients
Clinical trials
Using small data to target Alzheimer’s
Clinical trials
Combining existing medicines to target aging
Clinical trials
Longevity marketing and the need for clarity
Clinical trials
New immune aging drug brings Longevity and C19 hope
Clinical trials
Longevity trials: time to change the approach?
Clinical trials
Leading academic sees “great promise” in longevity supplements
Clinical trials
AKG study first to show “dramatically compressed” morbidity in mammals
Clinical trials
Healthy aging – it’s still all about diet and exercise. For now
Clinical trials
$2m Longevity boost for rapamycin Alzheimer’s study
Clinical trials
Load More